CAS No. Compound Cat. No.
085326-06-3 2', 3'- Dideoxyguanosine ( ddG ) D 039
10058-66-9 7- Deazaadenosine- 5'- O- triphosphate ( 7-CH-ATP ) D 096
100929-77-9 β- Nicotinamide adenine dinucleotide- 2', 3'- cyclic monophosphate ( NADcP+ / 2',3'-cyclic NADP+ ) N 050
101536-15-6 Cytidine- 5'- O- (α, β- methylene)diphosphate ( CMP-CP ) C 077
102029-95-8 Adenosine- 5'- O- phosphosulfate ( APS ) A 061
103078-56-4 7- Deaza- 2'- deoxyadenosine- 5'- O- monophosphate ( 7-CH-5'-dAMP / 5'-dTuMP ) D 058
103213-41-8 1, N6- Ethenoadenosine- 5'- O- monophosphate ( ε-5'-AMP ) E 005
103213-51-0 1, N6- Ethenoadenosine- 3', 5'- cyclic monophosphate ( ε-cAMP ) E 001
103213-52-1 1, N6- Ethenoadenosine- 5'- O- diphosphate ( ε-ADP ) E 007
1033893-75-2 8- (4- Mercaptobutylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-MBT-cAMP ) M 080
10414-81-0 2'- Amino- 2'- deoxyadenosine ( 2'-AdA ) A 104
104809-28-1 β- Nicotinamide- 1, N6- ethenoadenine dinucleotide phosphate ( ε-NADP+ ) N 024
104835-70-3 Adenosine- 5'- O- (α, β- methylene)diphosphate ( AMP-CP ) A 070
104872-93-7 2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cGMP ) M 023
10527-46-5 P1- (5'- Adenosyl)- P4- (5'- guanosyl)- tetraphosphate ( Ap4G / Gp4A ) A 177
10527-48-7 P1- (5'-  Adenosyl)- P4- (5'- uridyl)- tetraphosphate ( Ap4U / Up4A ) U 008
1053668-88-4 2', 3'- Dideoxyuridine- 5'- O- (1- thiotriphosphate) ( ddUTP-α-S ) D 028
105701-92-6 N6- Phenyladenosine- 5'- O- diphosphate ( 6-Phe-ADP ) P 014
105740-47-4 N6- Phenyladenosine- 5'- O- triphosphate ( 6-Phe-ATP ) P 015
1151916-53-8 8- Carboxyethylaminoadenosine ( 8-CEA-Ado ) C 092
1152197-23-3 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-pCPT-2'-O-Me-cAMP-AM ) C 051
115974-70-4 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-AET-cGMP ) A 029
115993-88-9 8- (2- [7- Nitro- 4- benzofurazanyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-NBD-cGMP ) N 001
116285-77-9 8- Chloroinosine ( 8-Cl-Ino ) C 019
117778-38-8 N6- Cyclopentyladenosine- 5'- O- monophosphate ( 6-cPe-5'-AMP ) C 089
118275-99-3 Adenosine- 2', 3'- cyclic monophosphorothioate, Rp- / endo isomer ( Rp-2',3'-cAMPS ) A 006
118276-00-9 Adenosine- 2', 3'- cyclic monophosphorothioate, Sp- / exo isomer ( Sp-2',3'-cAMPS ) A 024
1187179-94-7 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 5'- O- monophosphate ( 8-pCPT-2'-O-Me-5'-AMP ) C 078
1187179-96-9 8- (4- Chlorophenylthio)- 2'- O- methyladenosine ( 8-pCPT-2'-O-Me-Ado ) C 070
119340-53-3 Cyclic adenosine diphosphate ribose ( cADPR ) C 005
120496-69-7 2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-dADP-α-S ) D 005
120496-69-7 2'- Deoxyadenosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-dADP-α-S ) D 004
120912-54-1 5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Sp- isomer ( Sp-5,6-DCl-cBIMPS ) D 014
120912-55-2 5, 6- Dichlorobenzimidazole riboside- 3', 5' - cyclic monophosphorothioate, Rp- isomer ( Rp-5,6-DCl-cBIMPS ) D 013
1239610-11-7 2'- Deoxy- N6- (2- phenylethyl)adenosine- 5'- O- triphosphate ( 6-PhEt-dATP ) D 104
124615-99-2 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-dGTP ) D 086
124705-03-9 8- Chloroadenosine- 3', 5'- cyclic monophosphate ( 8-Cl-cAMP ) C 007
124844-92-4 2- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2-Cl-cAMPS ) C 073
124854-63-3 2- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-Cl-cAMPS ) C 074
1262426-04-9 β- Nicotinamide- 8- methylaminoadenine dinucleotide ( 8-MA-NAD+ ) N 025
127383-33-9 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-dGDP ) D 084
127634-20-2 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-cAMPS ) B 002
127634-21-3 4- Nitrobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 4-NO2-cBIMP ) N 007
128113-53-1 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-dATP ) D 085
128524-26-5 3'- Deoxythymidine- 5'- O- triphosphate ( dTTP ) / 2', 3'- Dideoxythymidine- 5'- O- triphosphate ( ddTTP ) D 038
129693-10-3 5, 6- Dichlorobenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DCl-cBIMP ) D 011
129693-12-5 6- Chloropurine riboside- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Cl-cPuMPS ) C 083
129693-13-6 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-CPT-cAMPS ) C 012
129693-15-8 6- Chloropurine riboside- 3', 5'- cyclic monophosphorothioate, Rp- isomer( Rp-6-Cl-cPuMPS ) C 082
129735-00-8 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-cAMPS ) B 001
129735-01-9 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-CPT-cAMPS ) C 011
130-50-7 Guanosine- 2'- O- monophosphate ( 2'-GMP ) G 022
131-83-9 Uridine- 2'- O- monophosphate ( 2'-UMP ) U 015
132619-65-9 2', 3'- Dideoxyadenosine- 5'- O- triphosphate ( ddATP ) D 018
132619-66-0 2', 3'- Dideoxycytidine- 5'- O- triphosphate ( ddCTP ) D 037
13276-43-2 2- Chloroinosine ( 2-Cl-Ino ) C 021
13276-52-3 2, 6- Dichloropurine riboside D 064
13389-03-2 8- Bromo- 2'- deoxyguanosine ( 8-Br-dGuo ) B 021
13484-60-1 Purine riboside- 5'- O- monophosphate ( 5'-PuMP ) P 011
1350460-89-7 2', 3'- O- ( Bis- [5- chloroanthraniloyl])adenosine- 5'- O- triphosphate ( Bis-Cl-ANT-ATP ) B 091
1350460-91-1 2', 3'- O- ( Bis- [5- bromoanthraniloyl])adenosine- 5'- O- triphosphate ( Bis-Br-ANT-ATP ) B 111
1350521-45-7 2'- / 3'- O- (5- Chloroanthraniloyl)adenosine- 5'- O- triphosphate ( Cl-ANT-ATP ) C 114
1350521-48-0 2'- / 3'- O- (5- Chloroanthraniloyl)inosine- 5'- O- triphosphate ( Cl-ANT-ITP ) C 132
1350521-49-1 2', 3'- O- (5- Bromoanthraniloyl)adenosine- 5'- O- triphosphate ( Br-ANT-ATP ) B 110
1352921-13-1 P1- (5'- Adenosyl)- P4- (5'- cytidyl)- tetraphosphate ( Ap4C / Cp4A ) A 178
13548-68-0 8- Chloroxanthine ( 8-Cl-X ) C 044
1357147-61-5 8-, 8'- Dibromo- cyclic diguanosine monophosphate ( 8,8'-Di-Br-c-diGMP ) D 113
1383539-73-8 4- Cyclopentyl- 2- (2, 5- dimethylbenzylsulfanyl)- 6- oxo- 1, 6- dihydropyrimidine- 5- carbonitrile ( HJC0197 ) C 136
13875-63-3 1, N6- Ethenoadenine ( ε-Ade ) E 012
142754-27-6 8- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Cl-cAMPS ) C 003
142754-28-7 8- Chloroadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Cl-cAMPS ) C 004
142754-31-2 5, 6- Dimethylbenzimidazole riboside- 3', 5'- cyclic monophosphate ( 5,6-DM-cBIMP ) D 001
14365-44-7 5'- Amino- 5'- deoxyadenosine ( 5'-NH2-Ado ) A 021
144509-87-5 8- (2- Aminophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-APT-cGMP ) A 032
144510-04-3 8- Bromo- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'-cyclic monophosphate ( 8-Br-PET-cGMP ) P 003
144510-13-4 8- (6- Aminohexylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-AHT-cGMP ) A 167
146-77-0 2- Chloroadenosine ( 2-Cl-Ado / 2-CADO ) C 017
148821-01-6 2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- [(β, γ)- imidotriphosphate] ( MANT-GppNHp ) M 047
148821-02-7 2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- diphosphate ( MANT-GDP ) M 041
148821-03-8 2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- triphosphate ( MANT-GTP ) M 032
149376-70-5 9- Acetyl- 6- chloroguanine A 135
14985-44-5 8- Bromo- 2'- deoxyadenosine ( 8-Br-dAdo ) B 027
150418-07-8 8- Bromoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-cGMPS ) B 005
151481-85-5 2'- / 3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-ADP ) M 040
151481-86-6 2'- /3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- triphosphate ( MANT-ATP ) M 030
151837-09-1 Adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cAMPS ), economy grade A 002 T
151898-26-9 8- Bromo- cyclic adenosine diphosphate ribose ( 8-Br-cADPR ) B 065
152218-18-3 N6- Benzoyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Bnz-cAMPS ) B 040
152218-23-0 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-O-MB-cAMPS ) M 005
152218-23-0 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-O-MB-cAMPS ) M 004
152218-24-1 Adenosine- 3', 5'- monophosphorothioate acetoxymethyl ester, Sp- isomer ( Sp-cAMPS-AM ) A 035
153660-03-8 8- Bromoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-cGMPS ) B 006
153660-04-9 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-pCPT-cGMPS ) C 013
154771-48-9 3'- Deoxythymidine- 5'- O- (1- thiotriphosphate) ( dTTP-α-S ) / 2', 3'- Dideoxythymidine- 5'- O- (1- thiotriphosphate) ( ddTTP-α-S ) D 029
154771-49-0 2', 3'- Dideoxycytidine- 5'- O- (1- thiotriphosphate) ( ddCTP-α-S ) D 027
154771-50-3 2', 3'- Dideoxyguanosine- 5'- O- (1- thiotriphosphate) ( ddGTP-α-S ) D 025
154902-26-8 2', 3'- Dideoxyadenosine- 5'- O- (1- thiotriphosphate) ( ddATP-α-S ) D 026
15548-51-3 Thymidine- 5'- O- monophosphorothioate ( 5'-TMPS ) T 004
15548-52-4 Uridine- 5'- O- monophosphorothioate ( 5'-UMPS ) U 006
156816-35-2 8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-PIP-cAMPS ) P 005
156816-36-3 8- Piperidinoadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-PIP-cAMPS ) P 004
15717-45-0 8- Bromo- 2', 3', 5'- tri- O- acetylguanosine ( 8-Br-2',3',5'-TAc-Guo ) B 038
15718-49-7 Guanosine- 2', 3'- cyclic monophosphate ( 2',3'-cGMP ) G 025
15718-50-0 Uridine- 2', 3'- cyclic monophosphate ( 2',3'-cUMP ) U 004
159764-93-9 Adenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cAMP-AM ) A 022
159910-48-2 N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( DB-cAMP-AM ) D 008
160385-87-5 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-cGMPS ) C 014
16174-58-6 2'- Deoxyadenosine- 3', 5'- O- bisphosphate ( pdAp ) D 092
16174-59-7 2'- Deoxyguanosine- 3', 5'- O- bisphosphate ( pdGp ) D 094
16321-98-5 2- Amino- 6- chloropurine riboside- 5'- O- monophosphate ( 2-NH2-6-Cl-5'-PuMP ) A 084
164007-71-0 Guanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cGMP-AM ) G 002
16506-88-0 2- Chloroadenosine- 5'- O- diphosphate ( 2-Cl-ADP ) C 055
16541-19-8 6- Thioguanosine- 5'- O- diphosphate ( 6-T-GDP ) T 015
16719-36-1 7- Deazaadenosine- 3', 5'- cyclic monophosphate ( 7-CH-cAMP ) D 021
16719-46-3 7- Deazaadenosine- 5'- O- monophosphate ( 7-CH-5'-AMP / 5'-TuMP ), sodium salt D 032
168701-80-2 8- Nitroguanine ( 8-NO2-Gua ) N 003
169335-91-5 N6- Phenyladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-6-Phe-cAMPS ), sodium salt P 029
169335-92-6 N6- Phenyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-Phe-cAMPS ) P 018
16980-89-5 N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), economy grade D 009 E
16980-89-5 N6, 2'- O- Dibutyryladenosine- 3', 5'- cyclic monophosphate ( DB-cAMP, Bucladesine ), high purity grade D 009
172806-20-1 8- Bromo- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-PET-cGMPS ) P 007
172806-21-2 8- Bromo- β -phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-PET-cGMPS ) P 008
173074-70-9 2'- / 3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- triphosphate ( 2'-/3'-AEC-ATP / EDA-ATP ) A 072
173964-83-5 6- (ß- D- 2- Deoxyribofuranosyl)- 3, 4- dihydro- 8H- pyrimido- [4, 5- c]- [1, 2]- oxazin- 7- one- 5'- O- triphosphate ( 2'-Deoxy-P-nucleoside-5'-O-triphosphate / dPTP ) D 114
17670-19-8 6- Thioguanosine- 5'- O- triphosphate ( 6-T-GTP ) T 016
181705-62-4 N6-(2- Phenylethyl)adenosine- 5'- O- triphosphate ( 6-PhEt-ATP ) P 012
1839-18-5 2- Chloroadenine ( 2-Cl-Ade ) C 040
185341-69-9 8- Chloroadenosine- 5'- O- diphosphate ( 8-Cl-ADP ) C 042
185341-71-3 8- Chloroadenosine- 5'- O- triphosphate ( 8-Cl-ATP ) C 018
187478-96-2 7- Deaza- 2'- deoxyadenosine- 5'- O- diphosphate ( 7-CH-dADP / 5'-dTuDP ) D 061
189278-08-8 N6- Methoxy- 2, 6- diaminopurine- 2'- deoxyriboside- 5'- O- triphosphate ( dKTP ) M 084
189822-11-5 N6- Cyclopentyladenosine- 5'- O- triphosphate ( 6-cPe-ATP ) C 062
189876-06-0 8- Bromo- 7- deaza- cyclic adenosine diphosphate ribose ( 8-Br-7-CH-cADPR ) B 100
189876-09-3 β- Nicotinamide- 8- bromo- 7- deazaadenine dinucleotide ( 8-Br-7-CH-NAD+ ) N 016
190522-24-8 8- Bromoadenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-cAMP-AM ) B 020
19341-57-2 Adenosine- 5'- O- monophosphorothioate ( 5'- AMPS ) A 005
2004-07-1 2- Amino- 6- chloropurine riboside ( 2-NH2-6-Cl-PuR ) A 080
205368-46-3 O6- Benzylguanosine- 3', 5'- cyclic monophosphate ( 6-Bn-cGMP ) B 043
205368-54-3 N2- Methylguanosine- 3', 5'- cyclic monophosphate ( 2-Me-cGMP) M 010
205368-58-7 N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate ( 2-AH-cGMP ) A 055
205379-91-5 2'- Deoxyuridine- 5'- O- monophosphorothioate ( 5'-dUMPS ) D 057
206978-73-6 N6- Cyclohexyladenosine- 5'- O- triphosphate ( 6-cHe-ATP ) C 084
2104-68-9 8- Chloroguanosine ( 8-Cl-Guo ) C 026
21080-53-5 7- Deazaadenosine- 5'- O- diphosphate ( 7-CH-ADP / 5'-TuDP ) D 091
21082-28-0 8- Hydroxyguanosine- 3', 5'- cyclic monophosphate ( 8-OH-cGMP ) H 016
21149-26-8 8- Hydroxyadenine ( 8-OH-Ade ) H 007
2140-11-6 2', 3'- Isopropylideneinosine I 005
2140-67-2 N², N²- Dimethylguanosine ( M22Guo ) D 016
2140-71-8 2'- O- Methylguanosine M 045
2140-79-6 2'- O- Methyladenosine ( 2'-O-Me-Ado ) M 054
214272-02-3 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-AHA-cAMPS ) A 085
214272-03-4 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AHA-cAMPS ) A 071
214272-05-6 8- (8- Amino- 3, 6- dioxaoctylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-ADOA-cAMP ) A 033
214276-80-9 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-AHA-cAMP ) A 053
214276-94-5 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-AHA-cAMPS ) A 068
21466-01-3 2- Chloroadenosine- 5'- O- monophosphate ( 2-Cl-5'-AMP ) C 054
215321-95-2 N6- (3- Methylbenzyl)adenosine- 5'- O- triphosphate ( 6-(3-MeBn)-ATP ) M 025
217313-72-9 β- Nicotinic acid- 1, N6- ethenoadenine dinucleotide phosphate ( ε-NAADP+ ) N 019
21870-09-7 8- Bromoguanosine- 5'- O- monophosphate ( 8-Br-5'-GMP ) B 057
22052-03-5 8- Chloroguanine ( 8-Cl-Gua ) C 027
221010-51-1 Uridine- 5'- O- (2- thiodiphosphate) ( UDP-β-S / UDP-beta-S ) U 011
22140-20-1 2- Methylthioadenosine- 5'- O- monophosphate ( 2-MeS-5'-AMP ) M 031
221904-78-5 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-AEA-cAMPS ) A 180
221904-84-3 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AEA-cAMPS ) A 094
221904-88-7 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-AET-cGMPS ) A 154
221904-92-3 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-AET-cGMPS ) A 198
221905-51-7 8- (2- [7- Nitro- 4- benzofurazanyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-NBD-cAMP ) N 002
23001-60-7 2- Aminopurine riboside- 5'- O- triphosphate ( 2-NH2-PuTP ) A 124
23197-96-8 Purine riboside- 5'- O- triphosphate ( PuTP ) P 009
23197-98-0 8- Bromoguanosine- 5'- O- triphosphate ( 8-Br-GTP ) B 012
23567-96-6 8- Bromoadenosine- 5'- O- monophosphate ( 8-Br-5'-AMP ) B 066
23567-97-7 8- Bromoadenosine- 5'- O- triphosphate ( 8-Br-ATP ) B 068
23600-16-0 8- Bromoadenosine- 5'- O- diphosphate ( 8-Br-ADP ) B 067
2391-46-0 Adenylyl- (3' --> 5')- adenosine ( ApA ) A 083
24386-93-4 5- Iodotubercidin ( 5-I-Tu ) / 7- Deaza- 7- iodoadenosine I 004
24719-82-2 N6- Carbamoylthreonyladenosine ( t6-Ado ) C 022
2504-55-4 3'- Amino- 3'- deoxyadenosine ( 3'-AdA ) A 063
25130-29-4 5- Chlorocytidine ( 5-Cl-C ) C 034
252889-13-7 N6- (1- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-(1-MeBu)-ATP ) M 027
252889-14-8 N6- (2- Methylbutyl)adenosine- 5'- O- triphosphate ( 6-(2-MeBu)-ATP ) M 029
26001-38-7 8- Mercaptoguanosine M 046
26184-65-6 P1, P2- Di- (uridine- 5')- diphosphate ( Up2U / UppU ) D 128
2627-69-2 5- Aminoimidazole- 4- carboxamide- 1- ß- D- ribofuranoside ( AICAR / Acadesine / Z- riboside ) A 103
263707-16-0 3- [5- (tert.- Butyl)isoxazol- 3- yl]- 2- [2- (3- chlorophenyl)hydrazono]- 3- oxopropanenitrile ( ESI-09 ) B 133
272445-71-3 8- Bromoguanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-cGMP-AM ) B 014
272445-72-4 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-pCPT-cGMP-AM ) C 033
280577-98-2 N6- (4- Aminobutyl)adenosine- 5'- O- triphosphate ( 6-AB-ATP ) A 074
28128-28-1 8- Chloroadenine ( 8-Cl-Ade ) C 023
2863-04-9 Thymidine- 3', 5'- O- bisphosphate ( pTp ) / 2'- Deoxythymidine- 3', 5'- O- bisphosphate T 012
2880-89-9 5- Chlorouridine ( 5-Cl-U ) C 035
289633-56-3 2'- / 3'- O- Anthraniloyladenosine- 5'- O- triphosphate ( ANT-ATP ) A 197
293296-57-8 8- (2- [ Fluoresceinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[Fluo]-cAMP / 8-[Fluo]-AET-cAMP ) F 002
2946-39-6 8- Bromoadenosine B 033
29789-88-6 P1, P2- Di- (cytidine- 5')- diphosphate ( Cp2C / CppC ) D 127
29851-57-8 8- Hydroxyadenosine ( 8-OH-Ado ) H 011
3001-46-5 8- Bromoxanthosine ( 8-Br-Xao ) B 039
30275-80-0 N6- Benzoyladenosine- 3', 5'- cyclic monophosphate ( 6-Bnz-cAMP ) B 009
3031-94-5 5- Aminoimidazole- 4- carboxamide- 1- ß- D- ribofuranoside- 5'- O- monophosphate ( AICAR-5'-MP / ZMP ) A 105
3056-18-6 2, 6- Dichloro- 2', 3', 5'- triacetylpurine riboside D 063
3066-84-0 8- Bromoguanine ( 8-Br-Gua ) B 058
3130-39-0 N6-  Methyladenosine- 5'- O- triphosphate ( 6-Me-ATP ) M 039
31319-70-7 Xanthosine- 3', 5'- cyclic monophosphate ( cXMP ) X 001
31356-95-3 8- Hydroxyadenosine- 3', 5'- cyclic monophosphate ( 8-OH-cAMP ) H 003
31357-06-9 8- Piperidinoadenosine- 3', 5'- cyclic monophosphate ( 8-PIP-cAMP ) P 002
3181-38-2 2', 3', 5'- Triacetylinosine T 006
31966-52-6 8- Azidoadenosine- 3', 5'- cyclic monophosphate ( 8-N3-cAMP ) A 014
32115-08-5 N6- Benzyladenosine- 3', 5'- cyclic monophosphate ( 6-Bn-cAMP ) B 008
32381-15-0 Guanosine- 5'- O- (α, β- methylene)diphosphate ( GMP-CP ) G 024
32387-56-7 5- Chloro- 2'- deoxycytidine ( 5-Cl-dC / CldC ) C 081
32465-18-2 Arabinoadenosine- 3', 5'- cyclic monophosphate ( ara-cAMP ) A 076
33008-99-0 5'- Phosphoguanylyl- (3' -> 5')- guanosine ( pGpG ) P 023
3373-53-3 2- Hydroxyadenine ( 2-OH-Ade ) H 017
337536-53-5 8- Nitroguanosine ( 8-NO2-Guo ) N 004
33823-18-6 8- Methylaminoadenosine- 3', 5' cyclic monophosphate ( 8-MA-cAMP ) M 001
339291-37-1 (7- Diethylaminocoumarin- 4- yl)methyladenosine- 3', 5'- cyclic monophosphate ( DEACM-caged cAMP ) D 042
339291-42-8 (7- Diethylaminocoumarin- 4- yl)methylguanosine- 3', 5'- cyclic monophosphate ( DEACM-caged cGMP ) D 043
339291-51-9 6, 7- Bis(carboxymethoxy)coumarin- 4- yl)methyl- adenosine- 3', 5'- cyclic monophosphate ( BCMCM-caged cAMP ) B 016
339291-52-0 [6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- guanosine- 3', 5'- cyclic monophosphate ( BCMCM-caged cGMP ) B 017
3398-50-3 5- Bromo- 2’, 3’- dideoxyuridine- 5'- O- triphosphate ( 5-Br-ddUTP ) B 003
34051-30-4 N6- Phenyladenosine- 3', 5'- cyclic monophosphate ( 6-Phe-cAMP ) P 006
3416-05-5 3'- Deoxythymidine / 2', 3'- Dideoxythymidine ( ddT ) D 040
342-69-8 6- Methylmercaptopurine riboside M 043
34408-14-5 8- Chloroadenosine ( 8-Cl-Ado ) C 006
34983-48-7 2- Methylthioadenosine- 5'- O- diphosphate ( 2-MeS-ADP ) M 020
35874-49-8 8- Aminoadenosine- 5'- O- triphosphate ( 8-NH2-ATP ) A 115
3593-47-3 5'- Phosphoadenylyl- (3' -> 5')- adenosine ( pApA ) P 033
3608-58-0 3'- Deoxyguanosine ( 3'-dG ) D 041
362-76-5 2', 3'- Isopropylideneguanosine ( 2',3'-Ipr-Guo ) I 007
36940-87-1 2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cAMP ) M 011
370091-64-8 [6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- 8- bromoadenosine- 3', 5'- cyclic monophosphate ( BCMCM-caged 8-Br-cAMP ) B 018
370091-68-2 [6, 7- Bis(carboxymethoxy)coumarin- 4- yl]methyl- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( BCMCM-caged 8-Br-cGMP ) B 019
37589-80-3 Guanosine- 5'- O- (3- thiotriphosphate) ( GTP-γ-S ) G 019
37676-40-7 8- Chloroadenosine- 5'- O- monophosphate ( 8-Cl-5'-AMP ) C 016
37839-81-9 Adenosine- 3', 5'- cyclic monophosphate ( cAMP ), sodium salt A 001
3868-31-3 8- Hydroxyguanosine ( 8-OH-Guo ) H 001
38806-38-1 β- Nicotinamide- 1, N6- ethenoadenine dinucleotide ( ε-NAD+ ) N 010
39007-51-7 1, N6- Ethenoadenosine ( ε-Ado ) E 011
39023-65-9 2- Chloroadenosine- 3', 5'- cyclic monophosphate ( 2-Cl-cAMP ) C 020
39118-26-8 2'- O- Monosuccinylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-MS-cGMP ) M 015
39824-30-1 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-AHA-cAMP ) A 011
40027-70-1 N2, N2, 7- Trimethylguanosine ( m2,2,7G / TMG ) T 009
4016-63-1 8- Bromoguanosine B 036
40269-29-2 2'- O- Methyladenosine- 3', 5'- cyclic monophosphate ( 2'-O-Me-cAMP ) M 050
403497-54-1 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-AEC-cAMP / 2'-EDA-cAMP ) A 098
40732-48-7 Guanosine- 3', 5'- cyclic monophosphate ( cGMP ) G 001
40811-89-0 N6- Benzyladenosine- 5'- O- diphosphate ( 6-Bn-ADP ) B 023
40871-55-4 N6- Benzoyladenosine- 5'- O- monophosphate ( 6-Bnz-5'-AMP ) B 109
40922-97-2 N6- Benzyladenosine- 5'- O- triphosphate ( 6-Bn-ATP ) B 024
4097-04-5 P1, P5- Di- (adenosine- 5')- pentaphosphate ( Ap5A / ApppppA ) D 055
4097-22-7 2', 3'- Dideoxyadenosine ( ddA ) D 002
4099-84-7 5'- Amino- 5'- deoxyguanosine ( 5'-NH2-Guo ) A 078
4105-39-9 2- Methylthioadenosine ( 2-MeS-Ado ) M 033
41092-64-2 Inosine- 3', 5'- cyclic monophosphate ( cIMP ) I 001
4130-19-2 P1, P4- Di- (guanosine- 5')- tetraphosphate ( Gp4G / GppppG ) D 119
4209-30-7 3'- Amino- 3'- deoxyadenosine- 5'- O- triphosphate ( 3'-NH2-ATP ) A 114
42204-44-4 5'- Azido- 5'- deoxyguanosine ( 5'-N3-Guo ) A 079
42467-66-3 2- Aminopurine riboside- 3', 5'- monophosphate ( 2-NH2-cPuMP ) A 027
4291-63-8 2- Chloro- 2'- deoxyadenosine ( Cladribine, 2-Cl-dAdo, CdA ) C 028
43170-89-4 2- Methylthioadenosine- 5'- O- triphosphate ( 2-MeS-ATP ) M 021
4360-06-9 3'- Amino- 3'- deoxyadenosine- 5'- O- diphosphate ( 3'-NH2-ADP ) A 107
4372-67-2 8- Azidoadenosine ( 8-N3-Ado ) A 045
437715-62-3 8- Chloro- 2'- deoxyguanosine ( 8-Cl-dGuo ) C 025
4471-88-9 8- Aza- N6- nonanoyladenine A 134
4682-43-3 2'- Deoxycytidine- 3', 5'- O- bisphosphate ( pdCp ) D 093
47151-76-8 Cytidine- 5'- O- monophosphorothioate ( 5'-CMPS ), sodium salt C 053
475084-30-1 8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-OH-cAMPS ) H 004
477782-33-5 β- Nicotinamide- 8- bromohypoxanthine dinucleotide ( 8-Br-NHD+ ) N 006
49564-60-5 2- Chloroadenosine- 5'- O- triphosphate ( 2-Cl-ATP ) C 039
497064-72-9 Cytidine- 5'- O- (2- thiodiphosphate) ( CDP-β-S ) C 079
50655-17-9 8- Benzylthioadenosine- 3', 5'- cyclic monophosphate ( 8-BT-cAMP ) B 015
50663-82-6 2- Aza- 1, N6- ethenoadenosine ( 2-Aza-ε-Ado ) A 086
50663-90-6 2- Aza- 1, N6- ethenoadenosine- 3', 5'- cyclic monophosphate ( 2-Aza-ε-cAMP ) A 015
51116-00-8 N2, 2'- O- Dibutyrylguanosine- 3', 5'- cyclic monophosphate ( DB-cGMP ) D 010
51116-01-9 8- Bromoguanosine- 3', 5'- cyclic monophosphate ( 8-Br-cGMP ), economy grade B 004 E
51116-01-9 8- Bromoguanosine- 3', 5'- cyclic monophosphate ( 8-Br-cGMP ), fluorescence grade B 004
51239-26-0 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-cGMP ), economy grade C 009 E
51239-26-0 8- (4- Chlorophenylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-cGMP ), fluorescence grade C 009
5148-64-5 4- Methylphenyl- 2, 4, 6- trimethylphenylsulfone ( ESI-05 ) M 092
52301-30-1 2- Chloroinosine- 3', 5'- cyclic monophosphate, sodium salt ( 2-Cl-cIMP ) C 029
52977-37-4 β- Nicotinamide- 8- bromoadenine dinucleotide ( 8-Br-NAD+ ) N 017
53-85-0 5, 6- Dichloro- 1- ß- D- ribofuranosyl benzimidazole ( DRB ) D 012
53546-96-6 8- (2- Aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-AET-cAMP ) A 141
53595-18-9 Adenosine- 5'- O- diphosphoribose phosphate ( ADPRP ) A 190
53696-59-6 8- Azidoadenosine- 5'- O- triphosphate ( 8-N3-ATP ) A 043
5399-87-1 6- Chloropurine riboside C 058
54447-84-6 Cyclic diadenosine monophosphate ( c-diAMP ) / cyclic bis (3' −> 5') diadenylic acid C 088
54925-33-6 Cytidine- 3', 5'- cyclic monophosphate ( cCMP ) C 001
550-33-4 Purine riboside ( PuR ) / Nebularine P 016
5502-96-5 β- Nicotinic acid adenine dinucleotide phosphate ( β-NAADP+ ) N 018
55065-40-2 Thymidine- 5'- O- (α, β- methylene)diphosphate ( TMP-CP ) T 008
5542-28-9 P1, P4- Di- (adenosine- 5')- tetraphosphate ( Ap4A / AppppA ) D 115
55443-13-5 2'- O- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 2'-O-MB-cAMP ) M 007
55673-61-5 6- Chloropurine riboside- 5'- O- triphosphate ( 6-Cl-PuTP ) C 049
5614-64-2 8- Hydroxyguanine ( 8-OH-Gua ) H 002
56632-58-7 Uridine- 3', 5'- cyclic monophosphate ( cUMP ) U 001
574-25-4 6- Mercaptopurine riboside M 044
58-63-9 Inosine I 006
58329-72-9 2'- O- Monobutyrylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-MB-cGMP ) M 006
5843-59-4 6- Chloropurine riboside- 5'- O- monophosphate ( 6-Cl-5'-PuMP ), sodium salt C 032
58976-48-0 Adenosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-ATP-α-S ) A 040
58976-49-1 Adenosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-ATP-α-S ) A 039
59128-86-8 6- Chloropurine riboside- 5'- O- diphosphate ( 6-Cl-PuDP ) C 015
59212-44-1 8- Hexylaminoadenosine- 3', 5'- cyclic monophosphate ( 8-HA-cAMP ) H 006
59259-77-7 8- Bromoadenosine- 5'- O- diphosphoribose ( 8-Br-ADPR ) B 051
59286-20-3 Adenosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-ADP-α-S ) A 038
59331-71-4 Adenosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-ADP-α-S ) A 037
59432-65-4 8- Azidoadenosine- 5'- O- diphosphate ( 8-N3-ADP ) A 044
59587-50-7 β- Nicotinamide- N6- (2- aminoethyl)adenine dinucleotide ( 6-AE-NAD+ ) N 013
5959-90-0 P1, P3- Di- (adenosine- 5')- triphosphate ( Ap3A / ApppA ) D 117
59985-21-6 P1, P4- Di- (uridine- 5')- tetraphosphate ( Up4U / UppppU ) D 129
60-92-4 Adenosine- 3' ,5'- cyclic monophosphate ( cAMP ), free acid form A 001 H
6027-83-4 Guanosine- 3'- O- monophosphate ( 3'-GMP ) G 021
60307-63-3 2'-, 2''- Dideoxy- cyclic diguanosine monophosphate ( 2',2''-Di-c-didGMP ) D 139
60448-20-6 2'- O- Monosuccinyladenosine- 3', 5'- cyclic monophosphate, tyrosylmethyl ester ( 2'-O-MS-TME-cAMP ) M 022
60508-81-8 2'- Deoxy- 1, N6- ethenoadenosine- 5'- O- monophosphate ( ε-5'-dAMP ) D 077
60731-47-7 8- Azidoadenosine- 5'- O- monophosphate, sodium salt ( 8-N3-5'-AMP ) A 179
60777-99-3 1, N6- Ethenoadenosine- 5'- O- triphosphate ( ε-ATP ) E 004
60902-12-7 8- Azido- 1, N6- ethenoadenosine- 3', 5'- cyclic monophosphate ( 8-N3-ε-cAMP ) A 077
61093-23-0 Cyclic diguanosine monophosphate ( c-diGMP ) / cyclic bis ( 3' −> 5' ) diguanylic acid C 057
612513-13-0 8- Bromo- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-Br-2'-O-Me-cAMP ) B 022
612513-15-2 8- (4- Hydroxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pHPT-2'-O-Me-cAMP ) H 010
612513-16-3 8- (4- Methoxyphenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pMeOPT-2'-O-Me-cAMP ) M 034
61363-29-9 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-AEA-cAMP ) A 016
61468-88-0 2'- Amino- 2'- deoxyadenosine- 5'- O- triphosphate ( 2'-NH2-ATP ) A 113
62471-63-0 2'- Deoxy- 8- hydroxyadenosine ( 8-OH-dAdo ) D 050
625112-42-7 8- (4- Chlorophenylthio)- 2'- O- methylguanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cGMP ) C 048
62742-71-6 Adenosine- 3', 5'- cyclic monophosphate, benzyl ester ( cAMP-Bn ) A 065
63142-71-2 1- β- D- Ribofuranosyl- 1, 2, 4- triazole- 3- carboxamide- 5'- O- triphosphate ( Ribavirin-5'-O-triphosphate / RTP ) R 001
634207-53-7 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cAMP / "007" ) C 041
634207-89-9 8- (2- Aminoethylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-AET-2'-O-Me-cAMP ) A 142
634208-34-7 8- Bromo- 2'- O- methyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-2'-O-Me-cAMPS ) B 031
634208-37-0 8- (4- Chlorophenylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-2'-O-Me-cAMPS ) C 052
63545-57-3 2'- Amino- 2'- deoxyadenosine- 5'- O- diphosphate ( 2'-NH2-ADP ) A 106
638195-70-7 8- Bromo- cyclic inosine diphosphate ribose ( 8-Br-N1-cIDPR ) B 071
64145-26-2 2'- Deoxyadenosine- 5'- O- monophosphorothioate ( 5'-dAMPS ) D 003
64145-27-3 2'- Deoxycytidine- 5'- O- monophosphorothioate ( 5'-dCMPS ) D 059
64183-27-3 2'- Deoxy- 2'- fluoroadenosine ( 2'-F-dAdo ) D 079
64649-87-2 N4, 2'- O- Dibutyrylcytidine- 3', 5'- cyclic monophosphate ( DB-cCMP ) D 075
65312-53-0 8- Aminoadenosine- 5'- O- diphosphate ( 8-NH2-ADP ) A 144
66048-53-1 2', 3', 5'- Tri- O- benzoylguanosine ( 2',3',5'-TBnz-Guo ) T 007
66311-08-8 N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 6-AE-cAMP ) A 096
66311-09-9 N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate ( 6-AH-cAMP ) A 031
66311-12-4 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-AEA-cAMP ) A 097
663941-66-0 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-CPT-cAMP-AM ) C 056
66492-86-2 Adenosine- 5'- O- triphosphoro- γ- 1- (5- sulfonic acid)naphthylamidate ( ATP-γ-AmNS ) A 176
66891-23-4 8- Bromo- 2'- deoxyguanosine- 5'- O- triphosphate ( 8-Br-dGTP ) B 070
66895-05-4 8- Azido- 1, N6- ethenoadenosine- 5'- O- triphosphate ( 8-N3-ε-ATP ) A 211
67190-31-2 8- Azaadenosine- 3', 5'- cyclic monophosphate ( 8-Aza-cAMP ) A 150
67313-23-9 3', 5'- Diamino- 3', 5'- dideoxyadenosine ( 3',5'-DA-ddA ) D 076
67460-15-5 7- Deaza- 2'- deoxyadenosine- 5'- O- triphosphate ( 7-CH-dATP ) D 033
681175-76-8 N6-(2- Phenylethyl)adenosine- 5'- O- diphosphate ( 6-PhEt-ADP ) P 013
681175-77-9 N6- (2- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-(2-MeBu)-ADP ) M 028
681175-78-0 N6- (3- Methylbenzyl)adenosine- 5'- O- diphosphate ( 6-(3-MeBn)-ADP ) M 024
681175-79-1 N6- Cyclopentyladenosine- 5'- O- diphosphate ( 6-cPe-ADP / cpADP ) C 061
68498-25-9 2'- Deoxy- 1, N6- ethenoadenosine ( ε-dAdo ) D 080
68726-28-3 2', 3'- Dideoxyguanosine- 5'- O- triphosphate ( ddGTP ) D 019
696574-56-8 8- (4- Methoxyphenylthio)adenine ( 8-pMeOPT-Ade ) M 061
696574-56-8 8- (4- Methoxyphenylthio)adenosine ( 8-pMeOPT-Ado ) M 062
696574-61-5 8- (4- Chlorophenylthio)adenine ( 8-pCPT-Ade ) C 069
69699-76-9 1, N6- Ethenoadenosine- 5'- O- diphosphoribose ( ε-ADPR / ε-ADP-ribose ) E 013
6974-78-3 8- Bromoadenine ( 8-Br-Ade ) B 052
70253-67-7 N6- Monobutyryladenosine- 3', 5'- cyclic monophosphate ( 6-MB-cAMP ) M 003
71214-29-4 Uridine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-UTP-α-S ) U 003
71214-30-7 Uridine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-UTP-α-S ) U 002
71376-97-1 Guanosine- 5'- O- (2- thiodiphosphate) ( GDP-β-S ) G 023
71481-44-2 Guanosine- 5'- O- (1- thiodiphosphate), Rp- isomer ( Rp-GDP-α-S ) G 012
71481-45-3 Guanosine- 5'- O- (1- thiodiphosphate), Sp- isomer ( Sp-GDP-α-S ) G 013
71774-13-5 Adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cAMPS ), high purity grade A 003 S
72218-69-0 Uridine- 5'- O- triphosphoro- γ- 1- (5- sulfonic acid)naphthylamidate ( UTP-γ-AmNS ) U 014
723313-27-7 N6- (6- [N- Methylanthraniloyl]hexylamino)adenosine-3', 5'- cyclic monophosphate ( 6-MAH-cAMP ) M 017
72549-36-1 8- (4- Chlorophenylthio)- N6- phenyladenosine- 3', 5'- cyclic monophosphate ( 8-CPT-6-Phe-cAMP ) C 043
73208-40-9 Adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cAMPS ), high purity grade A 002 S
732921-73-2 Uridine- 5'- O- (α, β- methylene)diphosphate ( UMP-CP ) U 009
73449-07-7 2'- Deoxy- 2'- fluoroadenosine- 5'- O- triphosphate ( 2'-F-ATP ) D 074
74686-78-5 6- Thioguanosine- 5'- O- monophosphate ( 6-T-5'-GMP ) T 014
749843-87-6 8- Hydroxyadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-OH-cAMPS ) H 005
75912-25-3 Adenosine- 1- N- oxid- 3', 5'- cyclic monophosphate ( 1-NO-cAMP ) A 023
76310-16-2 Guanosine- 5'- O- monophosphorothioate ( 5'-GMPS ) G 018
76567-90-3 Thymidine- 3', 5'- cyclic monophosphate ( cTMP ) T 005
76724-84-0 Guanosine- 5'- O- triphosphoro- γ- 1- (5- sulfonic acid)naphthylamidate ( GTP-γ-AmNS ) G 026
767272-34-4 N6- (4- Aminobutyl)adenosine- 5'- O- diphosphate ( 6-AB-ADP ) A 026
76939-46-3 8- Bromoadenosine- 3', 5'- cyclic monophosphate ( 8-Br-cAMP ), economy grade B 007 E
76939-46-3 8- Bromoadenosine- 3', 5'- cyclic monophosphate ( 8-Br-cAMP ), fluorescence grade B 007
771477-45-3 2'- Deoxyinosine- 5'- O- monophosphorothioate ( 5'-dIMPS ) D 060
78000-56-3 6- Bromotubercidin ( 8- Bromo- 7- deazaadenosine, 6-Br-Tu ) B 013
78033-42-8 N1- Aminoguanosine- 3', 5'- cyclic monophosphate ( 1-NH2-cGMP ) A 041
78080-27-0 β- Phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphate ( PET-cGMP ) P 001
78710-84-6 8- (4- Chlorophenylthio)adenosine- 5'- O- monophosphate ( 8-pCPT-5'-AMP ) C 101
788807-32-9 8- Bromo- 2'- O- monobutyryladenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-Br-MB-cAMPS ) B 010
79049-97-1 Uridine- 5'- O- (3- thiotriphosphate) ( UTP-γ-S ) U 010
79695-24-2 P1- (5'- Cytidyl)- P4- (5'- guanosyl)- tetraphosphate ( Cp4G / Gp4C ) C 112
79695-25-3 P1- (5'- Guanosyl)- P4- (5'- uridyl)- tetraphosphate ( Gp4U / Up4G ) G 027
79940-41-3 Cyclic diinosine monophosphate ( c-diIMP ) C 105
80015-76-5 3'- Amino- 3'- deoxyguanosine ( 3'-AdG ) A 064
80875-87-2 2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dATP-α-S ) D 007
80902-28-9 2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dGTP-α-S ) D 031
80902-29-0 2'- Deoxyguanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dGTP-α-S ) D 030
80951-75-3 2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dCTP-α-S ) D 047
80951-76-4 2'- Deoxycytidine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dCTP-α-S ) D 046
81004-54-8 2'- Deoxy- 1, N6- ethenoadenosine- 5'- O- triphosphate ( ε-dATP ) D 078
81356-81-2 2'- Deoxy- 2'- fluoroadenosine- 3', 5'- cyclic monophosphate ( 2'-F-dcAMP ) D 073
81570-50-5 Guanosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-GTP-α-S ) G 014
81570-51-6 Guanosine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-GTP-α-S ) G 015
81611-03-2 7- Deazaguanosine- 3', 5'- cyclic monophosphate ( 7-CH-cGMP ) D 099
81921-35-9 N6- Methyladenosine- 5'- O- monophosphate ( 6-Me-5'-AMP ) M 038
82927-68-2 8- (4- Aminobutylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-ABA-cAMP ) A 017
83199-32-0 Thymidine- 5'- O- (1- thiotriphosphate), Sp-isomer ( Sp-TTP-α-S ) / 2'- Deoxythymidine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dTTP-α-S ) T 003
83199-35-3 Thymidine- 5'- O- (1- thiotriphosphate), Rp-isomer ( Rp-TTP-α-S ) / 2'- Deoxythymidine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dTTP-α-S ) T 002
83707-14-6 2'- O- (N- Methylanthraniloyl)adenosine- 3', 5'- cyclic monophosphate ( MANT-cAMP ) M 008
83707-15-7 2'- O- (N- Methylanthraniloyl)guanosine- 3', 5'- cyclic monophosphate ( MANT-cGMP ) M 009
84-52-6 Cytidine- 3'- O- monophosphate ( 3'-CMP ) C 094
84-53-7 Uridine- 3'- O- monophosphate ( 3'-UMP ) U 016
84230-52-4 Cytidine- 5'- O- triphosphoro- γ- 1- (5- sulfonic acid)naphthylamidate ( CTP-γ-AmNS ) C 106
84433-46-5 N6- Mono- tert. butylcarbamoyladenosine- 3', 5'- cyclic monophosphate ( 6-MBC-cAMP ) M 012
847649-49-4 8- Bromo- 2'- O- methylguanosine ( 8-Br-2'-O-Me-Guo ) B 034
849214-01-3 2'- O- Methyl- cyclic diguanosine monophosphate ( 2'-O-Me-c-diGMP ) M 086
849214-02-4 2'-, 2''- O- ( Di- methyl)- cyclic diguanosine monophosphate ( 2',2''-Di-O-Me-c-diGMP ) D 136
849214-04-6 Cyclic (adenosine monophosphate- guanosine monophosphate) ( c-(ApGp) / cGAMP / cyclic GMP-AMP / cyclic-AMP-GMP ) C 117
85-94-9 Cytidine- 2'- O- monophosphate ( 2'-CMP ) C 093
85065-24-3 P1, P2- Di- (adenosine- 5')- diphosphate ( Ap2A / AppA ) D 054
852657-04-6 8- (4- Chlorophenylthio)guanine ( 8-pCPT-Gua ) C 076
85280-65-5 5- (3- Aminoallyl)- 2'- deoxyuridine- 5'- O- triphosphate ( AA-dUTP ) A 116
85280-66-6 5- (3- Aminoallyl)uridine- 5'- O- triphosphate ( AA-UTP ) A 117
85287-53-2 2'- / 3'- O- (N'- Methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-AMP ) M 037
85287-54-3 2'-/ 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-GMP ) M 042
85352-87-0 8- (4- Chlorophenylthio)adenosine ( 8-pCPT-Ado ) C 086
85562-55-6 8- Chloro- 2'- deoxyadenosine ( 8-Cl-dAdo ) C 024
856702-89-1 Cyclic inosine diphosphate ribose ( N1-cIDPR ) C 098
85819-83-6 2'- Amino- 2'- deoxyadenosine- 3', 5'- cyclic monophosphate ( 2'-NH2-cAMP ) A 088
86562-09-6 Guanosine- 3', 5'- cyclic monophosphorothioate, Rp-isomer ( Rp- cGMPS ) G 016
86562-10-9 Guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cGMPS ) G 017
87063-79-4 Cytidine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-cCMPS ) C 065
87063-81-8 Cytidine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cCMPS ) C 066
87358-15-4 2'- Deoxyadenosine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dATP-α-S ) D 006
87358-26-7 2'- Deoxyguanosine- 5'- O- monophosphorothioate ( 5'-dGMPS ) D 056
876068-86-9 2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Rp- isomer ( Rp-dUTP-α-S ) D 048
876068-87-0 2'- Deoxyuridine- 5'- O- (1- thiotriphosphate), Sp- isomer ( Sp-dUTP-α-S ) D 049
88453-52-5 Adenosine- 5'- O- (3- thiotriphosphate) ( ATP-γ-S / ATP-gamma-S ) A 060
88847-89-6 2'- Deoxy- 8- hydroxyguanosine ( 8-OH-dGuo ) D 022
890-38-0 2'- Deoxyinosine D 062
908117-27-1 8- Phenylthioadenine ( 8-PT-Ade ) P 031
908117-27-1 8- Phenylthioadenosine ( 8-PT-Ado ) P 032
909782-76-9 8- (4- [N- Methylanthraniloyl]aminobutylamino)adenosine- 3', 5'- cyclic monophosphate ( 8-MABA-cAMP ) M 016
91828-83-0 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- diphosphate ( MANT-dADP ) D 083
92410-99-6 8- Bromo- 2'- deoxyadenosine- 5'- O- triphosphate ( 8-Br-dATP ) B 069
93602-66-5 Adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-cAMPS ), economy grade A 003 T
93839-95-3 2'- Deoxyadenosine- 3', 5'- cyclic monophosphate ( 2'-dcAMP ) D 015
93882-12-3 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-CPT-cAMP ), economy grade C 010 E
93882-12-3 8- (4- Chlorophenylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-CPT-cAMP ), fluorescence grade C 010
939028-75-8 Adenosine- 5'- O- diphospho- (1''- (4- nitrophenoxy)- ribose) ( ADPR-pNP ) A 184
93919-42-7 2'- Deoxyguanosine- 3', 5'- cyclic monophosphate ( 2'-dcGMP ) D 020
94200-58-5 6- Chloropurine riboside- 3', 5'- cyclic monophosphate ( 6-Cl-cPuMP ) C 002
944834-42-8 N6- Benzyladenosine- 5'- O- (3- thiotriphosphate) ( 6-Bn-ATP-γ-S ) B 072
944834-43-9 N6- (2- Phenylethyl)adenosine- 5'- O- (3- thiotriphosphate) ( 6-PhEt-ATP-γ-S ) P 026
956935-50-5 8- (4- Chlorophenylthio)- 2'- O- methylguanosine ( 8-pCPT-2'-O-Me-Guo ) C 102
961-07-9 2'- Deoxyguanosine D 065
96990-16-8 2- Chloro- 8- methylaminoadenosine- 3', 5'- cyclic monophosphate ( 2-Cl-8-MA-cAMP ) C 080
98088-66-5 1, N6- Ethenoadenosine- 5'- O- diphosphoribose phosphate ( ε-ADPRP ) E 016
98346-15-7 2', 3'- O- para- Anisylideneguanosine ( 2',3'-O-pAnisyl-Guo ) A 081
none 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2-AHA-cAMPS-Agarose ) A 069
none 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2-AEA-cAMPS-Agarose ) A 087
none 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AHA-cAMPS-Agarose ) A 013
none 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AEC-cAMPS-Agarose ) A 122
none 2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cGMPS-Agarose ) A 052
none 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-8-AHA-cAMPS-Agarose ) A 012
none 2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-2'-AHC-cGMPS-Agarose ) A 051
none 2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-2'-AHC-cAMPS-Agarose ) A 050
none 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AET-cGMPS-Agarose ) A 010
none 8- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AHA-cAMP-Agarose ) A 028
none 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-8-AET-cGMPS-Agarose ) A 009
none 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-8-AEA-cAMPS-Agarose ) A 008
none 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AEC-cAMP-Agarose ) A 112
none 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer, immobilized on agarose gel ( Rp-8-AEA-cAMPS-Agarose ) A 007
none N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AE-cAMP-Agarose ) A 111
none 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AEA-cAMP-Agarose ) A 110
none N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AE-cAMPS-Agarose ) A 109
none 2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AHC-cGMP-Agarose ) A 059
none N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, immobilized on agarose gel ( Sp-6-AH-cAMPS-Agarose ) A 108
none 2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2'-AHC-cAMP-Agarose ) A 058
none 8- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AEA-cAMP-Agarose ) A 020
none 8- (2- Aminoethylthio)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AET-cGMP-Agarose ) A 019
none 8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 8-AHA-2'-O-Me-cAMP-Agarose ) A 057
none N2- (6- Aminohexyl)guanosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AH-cGMP Agarose ) A 056
none N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 6-AH-cAMP-Agarose ) A 036
none 2- (6- Aminohexylamino)adenosine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 2-AHA-cAMP-Agarose ) A 054
pending 8- Phenylethylthio- cyclic inosine diphosphate ribose ( 8-PhEtT-N1-cIDPR ) P 034
pending 2'- / 3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- monophosphate ( 2'-/3'-AEC-5'-AMP ) A 172
pending PKG inhibitor peptide DT-2 D 051
pending N6- Furfuryladenosine- 5'- O- diphosphate ( 6-Fu-ADP ) F 006
pending 8- Bromo- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Br-2'-O-Me-cAMP-AM ) B 028
pending 8- (2- [ Biotinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[Biotin]-AET-cGMP ) B 025
pending β- (4- Azidophenyl)- 1, N2- etheno- 8- bromoguanosine- 3', 5'- cyclic monophosphate ( 4-N3-PET-8-Br-cGMP ) A 102
pending 2- (8- Amino- 3, 6- dioxaoctylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-ADOA-cAMP ) A 136
pending 2'- (6- [ Fluoresceinyl]aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cGMP / FAM-cGMP ) F 004
pending 8- Bromo- 2'- O- methylguanosine- 3', 5'- cyclic monophosphate ( 8-Br-2'-O-Me-cGMP ) B 037
pending N6- (2- Aminoethyl)- 8- azidoadenosine- 3', 5'- cyclic monophosphate ( 6-AE-8-N3-cAMP ) A 101
pending 2'- , 2''- O- ( Di- [6- aminohexylcarbamoyl])- cyclic diguanosine monophosphate ( 2',2''-Di-AHC-c-diGMP ) D 112
pending 8- [ Pharos-450]- adenosine- 3', 5'- cyclic monophosphate ( 8-[φ-450]-cAMP ) P 024
pending 2'- O- (N'- Methylanthraniloyl)cytidine- 3', 5'- cyclic monophosphate ( MANT-cCMP ) M 053
pending 2'-, 2''- O- ( Di- 6- [biotinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2',2''-Di-[Biotin]-AHC-c-diGMP ) D 111
pending 8- (2- [ DY-647]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-647]-AET-cGMP ) D 090
pending 8- Azido- N6- (2- [DY-547]- aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 8-N3-6-[DY-547]-AE-cAMP ) A 100
pending 2'- O- (6- [ DY-547]- aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-[DY-547]-AHC-c-diGMP ) D 116
pending β- Nicotinamide- N6- (2- (6- [fluoresceinyl]aminohexanoyl)aminoethyl)adenine dinucleotide ( 6-Fluo-10-NAD+ ) N 023
pending 2'-, 2''- O- ( Di- N'- methylanthraniloyl)- cyclic diguanosine monophosphate ( Di-MANT-c-diGMP ) D 101
pending 2'- /3'- O- (2- Aminoethylcarbamoyl)adenosine- 5'- O- diphosphate ( 2'-/3'-AEC-ADP / EDA-ADP ) A 118
pending β- Nicotinamide- 8- ethylthioadenine dinucleotide ( 8-ET-NAD+ ) N 038
pending 2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AHC-cGMPS ) A 067
pending N6- Cyclopentyladenosine- 5'- O- (3- thiotriphosphate) ( 6-cPe-ATP-γ-S ) C 116
pending β- Nicotinamide- N6- (2- (6- [biotinyl]aminohexanoyl)aminoethyl)adenine dinucleotide ( 6-Biotin-17-NAD+ ) N 012
pending 2'- O- (6- [ Biotinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-[Biotin]-AHC-c-diGMP ) B 098
pending 8- (2- [ DY-547]- aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-cGMP / 8-DY547-cGMP ) D 087
pending 8- (6- Aminohexylamino)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-AHA-2'-O-Me-cAMP ) A 099
pending 8- Bromo- cyclic diguanosine monophosphate ( 8-Br-c-diGMP ) B 099
pending 2'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-Fluo-AHC-c-diGMP ) F 009
pending β- Nicotinamide- 8- cyclopentylthioadenine dinucleotide ( 8-cPeT-NAD+ ) N 037
pending 2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AHC-cAMPS ) A 066
pending 6- Hexylthioguanosine- 3', 5'- cyclic monophosphate ( 6-HT-cGMP ) H 012
pending 2'- O- (6- Aminohexylcarbamoyl)- cyclic diguanosine monophosphate ( 2'-AHC-c-diGMP ) A 151
pending 2'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-Fluo-AHC-c-diAMP ) F 011
pending 2'- O- (6- [DY505-05]- aminohexylcarbamoyl))guanosine-3',5'-cyclic monophosphate ( 2'-[DY-505-05]-AHC-cGMP ) D 135
pending 2'- O- (6- Aminohexylcarbamoyl)- cyclic diguanosine monophosphate, immobilized on agarose ( 2'-AHC-c-diGMP-Agarose ) A 153
pending 2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-AHC-cGMP ) A 048
pending β- Nicotinamide- 8- (4- chlorophenylthio)adenine dinucleotide ( 8-pCPT-NAD+ ) N 033
pending N6- (3- [([ Biotinyl]- 3- aminopropoxy(ethoxy)ethoxy)ethoxy]ethoxypropyl)adenosine- 5'- O- diphosphate ( 6-[Biotin]-APrO-(EO)4-Pr-ADP ) B 077
pending N6- Cyclohexyladenosine- 5'- O- (3- thiotriphosphate) ( 6-cHe-ATP-γ-S) C 127
pending 2'- / 3'- O- (6- [ Tetramethylrhodaminyl]aminoethylcarbamoyl)guanosine- 5'- O- monophosphate ( 2'-/3'-TAMRA-AEC-5'-GMP ) T 020
pending N6- Furfuryladenosine- 5'- O- (3- thiotriphosphate) ( 6-Fu-ATP-γ-S ) F 008
pending 2- (6- [ Biotinyl]aminohexylamino)adenosine- 3', 5'- cyclic monophosphate ( 2-[Biotin]-AHA-cAMP ) B 041
pending PKG inhibitor peptide (D)-DT-2 D 110
pending 2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-AHC-cAMP ) A 046
pending β- Nicotinamide- 8- butylthioadenine dinucleotide ( 8-BuT-NAD+ ) N 036
pending 8- Carboxyethylaminoadenine ( 8-CEA-Ade ) C 091
pending 2'- O- (6- Aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AHC-cAMPS ) A 120
pending Cytidine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( cCMP-AM ) C 067
pending 2'- / 3'- O- (N'- Methylanthraniloyl)inosine- 5'- O- monophosphate ( MANT-5'-IMP ) M 072
pending 2'- / 3'- O- (6- Aminohexylcarbamoyl)uridine- 5'- O- triphosphate ( 2'-/3'-AHC-UTP ) A 155
pending 2', 2''- O- ( Di- (6- [biotinyl]aminohexylcarbamoyl))- cyclic diadenosine monophosphate ( 2',2''-Di-[Biotin]-AHC-c-diAMP ) D 122
pending 2'- , 2''- O- ( Di- [6- aminohexylcarbamoyl])- cyclic diadenosine monophosphate ( 2',2''-Di-AHC-c-diAMP ) D 121
pending 2'- / 3'- O- (6- [ Fluoresceinyl]aminohexylcarbamoyl)adenosine- 5'- O- monophosphate ( 2'- / 3'-Fluo-AHC-5'-AMP ) F 010
pending 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AEC-cAMPS / Rp-2'-EDA-cAMPS ) A 119
pending 8- Bromoinosine- 5'- O- diphosphoribose ( 8-Br-IDPR ) B 082
pending 2'- O- (2- Aminoethylcarbamoyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2'-AEC-cAMPS / Sp-2'-EDA-cAMPS ) A 095
pending 2'- O- (6- Aminohexylcarbamoyl)- cyclic diadenosine monophosphate, immobilized on agarose ( 2'-AHC-c-diAMP-Agarose ) A 183
pending 8- Methylthio- cyclic inosine diphosphate ribose ( 8-MeS-N1-cIDPR ) M 064
pending 8- Chloroadenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 8-Cl-cAMP-AM ) C 050
pending 2'- / 3'- O- (6- Aminohexylcarbamoyl)guanosine- 5'- O- triphosphate ( 2'-/3'-AHC-GTP ) A 188
pending 2'- O- (6- [ Biotinyl]aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-[Biotin]-AHC-c-diAMP ) B 106
pending 8- Azaadenosine- 5'- O- monophosphate ( 8-Aza-5'-AMP ) A 149
pending 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)guanosine- 5'- O- monophosphate ( MANT-5'-dGMP ) D 082
pending 2'- O- (6- Aminohexylcarbamoyl)- cyclic diadenosine monophosphate ( 2'-AHC-c-diAMP ) A 182
pending 2'- O- (2- [ Tetramethylrhodaminyl]aminoethylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-TAMRA-AEC-cGMP ) T 018
pending 8- Methylamino- cyclic inosine diphosphate ribose ( 8-MA-N1-cIDPR ) M 063
pending 2', 3'- O- ( Bis- anthraniloyl)adenosine- 5'- O- triphosphate ( Bis-ANT-ATP ) B 090
pending 8- (6- Aminohexylthio)guanosine- 5'- O- triphosphate ( 8-AHT-GTP ) A 191
pending N4- (6- Aminohexyl)cytidine- 3', 5'- cyclic monophosphate ( 4-AH-cCMP ) A 143
pending 2'- Deoxy- 3'- O- (N'- methylanthraniloyl)adenosine- 5'- O- monophosphate ( MANT-5'-dAMP ) D 081
pending 2'- O- (6- [ Tetramethylrhodaminyl]aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-TAMRA-AHC-cGMP ) T 017
pending 8- Dimethylamino- cyclic inosine diphosphate ribose ( 8-DMA-N1-cIDPR ) D 108
pending N6- (3-[ Biotinyl]aminopropyl)adenosine- 5'- O- diphosphate ( 6-[Biotin]-APr-ADP ) B 076
pending 8- (2- Aminoethylthio)- cyclic inosine diphosphate ribose ( 8-AET-N1-cIDPR ) A 140
pending 8- (2- Aminoethylthio)guanosine- 5'- O- triphosphate ( 8-AET-GTP ) A 192
pending 8- Azido- N6- (2- [biotinyl]aminoethyl)adenosine- 3', 5'- cyclic monophosphate ( 8-N3-6-[Biotin]-AE-cAMP ) A 127
pending 2- (2- Aminoethylamino)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-2-AEA-cAMPS ) A 093
pending 8- (2- [ Fluoresceinyl]aminoethylthio)guanosine- 3', 5'- cyclic monophosphate ( 8-[Fluo]-cGMP / 8-[Fluo]-AET-cGMP ) F 001
pending N6- Cyclohexyladenosine- 5'- O- diphosphate ( 6-cHe-ADP ) C 085
pending 8- (4-  Chlorophenylthio)- cyclic inosine diphosphate ribose ( 8-pCPT-N1-cIDPR ) C 100
pending 8- (4- Chlorophenylthio)- 2'- O- methylxanthosine- 3', 5'- cyclic monophosphate ( 8-pCPT-2'-O-Me-cXMP ) C 059
pending Guanosine- 5'- O- diphosphate, immobilized on a polymeric matrix ( GDP-Gel / GDP-Agarose ) G 028
pending 8- [ Pharos-575]- guanosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-cGMP ) P 020
pending N6- Benzoyladenosine- 3', 5'- cyclic monophosphate, acetoxymethyl ester ( 6-Bnz-cAMP-AM ) B 079
pending N6- (2- Aminoethyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-AE-cAMPS ) A 092
pending 2'- , 2''- Dideoxy- 2'-, 2''- difluoro- cyclic diadenosine monophosphate ( 2',2''-Di-F-c-didAMP ) D 132
pending 8- (4-  tert.- Butylbenzylthio)- cyclic inosine diphosphate ribose ( 8-ptBBT-N1-cIDPR ) B 086
pending 8- Nitroguanosine- 3', 5'- cyclic monophosphate ( 8-NO2-cGMP ) N 011
pending Cytidine- 5'- O- diphosphate, immobilized on a polymeric matrix ( CDP-Gel / CDP-Agarose ) C 128
pending 2'- O- (2- Aminoethylcarbamoyl)guanosine- 3', 5'- cyclic monophosphate ( 2'-AEC-cGMP ) A 075
pending 2'- / 3'- O- (6- Aminohexylcarbamoyl)cytidine- 5'- O- triphosphate ( 2'-/3'-AHC-CTP ) A 157
pending N2- (6- [ Biotinyl]aminohexyl)guanosine- 3', 5'- cyclic monophosphate ( 2-[Biotin]-AH-cGMP ) B 032
pending N6- (1- Methylbutyl)adenosine- 5'- O- diphosphate ( 6-(1-MeBu)-ADP ) M 026
pending Phosphate tris(acetoxymethyl)ester ( PO4-AM3 ) P 030
pending N6- (6- Aminohexyl)adenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-6-AH-cAMPS ) A 089
pending Cyclic diadenosine monophosphorothioate, Sp- isomer ( Sp-c-diAMPS ) C 122
pending Ethanolamine; immobilized on agarose gel ( EtOH-NH-Agarose ) E 010
pending 8- Bromo- 7- deazaadenosine- 5'- O- diphosphoribose ( 8-Br-7-CH-ADPR ) B 103
pending N4- (6- Aminohexyl)cytidine- 3', 5'- cyclic monophosphate, immobilized on agarose gel ( 4-AH-cCMP-Agarose ) A 147
pending 2'- / 3'- O- (6- Aminohexylcarbamoyl)guanosine- 5'- O- monophosphate ( 2'-/3'-AHC-5'-GMP ) A 174
pending 8- (4- Chlorophenylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphate ( 8-pCPT-PET-cGMP ) C 045
pending N6- (1- Methylbutyl)adenosine- 5'- O- (3-thiotriphosphate) ( 6-(1-MeBu)-ATP-γ-S ) M 074
pending 8- (4- Chlorophenylthio)guanosine ( 8-pCPT-Guo ) C 060
pending 2'- (6- [ Fluoresceinyl]aminohexylcarbamoyl)adenosine- 3', 5'- cyclic monophosphate ( 2'-Fluo-AHC-cAMP / FAM-cAMP ) F 003
pending 8- (2- [ Biotinyl]aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[Biotin]-AET-cAMP ) B 030
pending Cyclic diadenosine monophosphorothioate, Rp- isomer ( Rp-c-diAMPS ) C 121
pending 8- [ Pharos-575]- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-2'-O-Me-cAMP ) P 021
pending 8- Benzylthio- cyclic inosine diphosphate ribose ( 8-BT-N1-cIDPR ) B 085
pending 8- (2- [ DY-547]- aminoethylthio)- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-2'-O-Me-cAMP ) D 089
pending 2'- / 3'- O- (6- Aminohexylcarbamoyl)adenosine- 5'- O- monophosphate ( 2'-/3'-AHC-5'-AMP ) A 171
pending 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer, acetoxymethyl ester ( Sp-8-Br-cAMPS-AM ) B 029
pending PKG inhibitor peptide W45 W 001
pending 8- [ Pharos-575]- adenosine- 3', 5'- cyclic monophosphate ( 8-[φ-575]-cAMP ) P 019
pending 8- Hydroxy- 2'- O- methyladenosine- 3', 5'- cyclic monophosphate ( 8-OH-2'-O-Me-cAMP ) H 013
pending 2'- / 3'- O- (2- Aminoethylcarbamoyl)guanosine- 5'- O- monophosphate ( 2'-/3'-AEC-5'-GMP ) A 170
pending PKG inhibitor peptide DT-3 D 052
pending N6- Furfuryladenosine- 5'- O- triphosphate ( 6-Fu-ATP ) F 007
pending ß- ara- 2'- Deoxy- 2'- fluoro- nicotinamide adenine dinucleotide ( ara-2'-F-NAD+ ) D 148
pending 4, 6- Dinitrobenzimidazole riboside- 3', 5'- cyclic monophosphate (4,6-DN-cBIMP) D 069
pending 8- [ Pharos-450]- guanosine- 3', 5'- cyclic monophosphate ( 8-[φ-450]-cGMP ) P 025
pending 8- Azido- 1, N6- ethenoadenosine- 5'- O- diphosphate ( 8-N3-ε-ADP ) A 210
pending 8- (2- [DY-547]- aminoethylthio)adenosine- 3', 5'- cyclic monophosphate ( 8-[DY-547]-AET-cAMP / fcAMP ) D 109
[1262749-61-0] 2'- O- (6- Aminohexylcarbamoyl)guanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-2'-AHC-cGMPS ) A 123
[1262749-62-1] 8- (4- Chlorophenylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer ( Rp-8-pCPT-PET-cGMPS ) C 046
[1262749-63-2] 8- (4- Chlorophenylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-pCPT-PET-cGMPS ) C 047
[949909-73-3] 2'- O- Methylguanosine- 3', 5'- cyclic monophosphate ( 2'-O-Me-cGMP ) M 036
[pending] 8- (6- [ Fluoresceinyl]aminohexylthio)- ß- phenyl- 1, N²- ethenoguanosine- 3', 5'- cyclic monophosphate ( 8-[Fluo]-AHT-PET-cGMP ) F 012
[pending] 2'- O- (6- Aminohexylcarbamoyl)cytidine- 3', 5'- cyclic monophosphate ( 2'-AHC-cCMP ) A 156
<< Back
Login

Forgot your password?

Register

What is new!

February 11, 2013

NEW: Epac Inhibitors !

Three novel membrane-permeant inhibitors of the exchange protein directly activated by cyclic AMP... [more...]

January 11, 2013

Cyclic GMP-AMP (cGAMP) available !

Cyclic (adenosine monophosphate- guanosine monophosphate) (c-(ApGp), cyclic GMP-AMP or cGAMP, BIO... [more...]